Own Pain Relief Solution Store In Your City | Franchise Sales & Distribution Call us on 8691006638
Progesterone plays a vital role in maintaining a healthy pregnancy and supporting hormonal equilibrium. Developed by RIHCA (Rawia International Healthcare), PROGESTERONE RETARD 250 mg is a premium injectable formulation designed for sustained release, ensuring consistent hormonal support for women’s health. Available globally through our Rawiacare and Rawiacare Global platforms, this product meets the highest pharmaceutical standards to prevent complications and support high-risk pregnancies.
Our Mission: To Share • To Care • To Inspire.
PROGESTERONE RETARD RIHCA® 250 mg contains Hydroxyprogesterone, a long-acting synthetic hormone essential for reproductive health.
Mechanism of Action: Effectively supports embryo implantation and maintains uterine tranquility to reduce the risk of early pregnancy loss.
Sustained Release: Engineered for prolonged efficacy, reducing the frequency of administration compared to standard formulations.
Clinical Positioning: Indicated for habitual abortion, luteal phase support, and secondary amenorrhea.
| Clinical Positioning: |
| Preventive hormonal therapy |
| Early pregnancy support |
| Mild to moderate progesterone deficiency |
| Specifications Table | |
| Parameter | Details |
| Brand Name | PROGESTERONE RETARD RIHCA® |
| Active Ingredient | Hydroxyprogesterone Caproate |
| Arabic Name | بروجستيرون ريتارد ريهكا |
| Category | Hormonal Therapy |
| Therapeutic Area | Women’s Health / Obstetrics & Gynecology |
| Subcategory | Progestins |
| Dosage Form | Injectable (Sustained Release) |
| Strength / Volume | 250 mg / 2 ml |
| Platform Name | RAWIACARE / RAWIACARE GLOBAL |
| Route / Type | Intramuscular (Depot) |
| Release Type | Long-Acting (Retard) |
| Developed By | RIHCA (Rawia International Healthcare) |
| Platform Name | RAWIACARE / RAWIACARE GLOBAL |
| Early pregnancy support |
| Prevention of early miscarriage |
| Management of progesterone deficiency |
| Luteal phase hormonal support |
| Hormonal stabilization in women’s health |
| It is used for early pregnancy support and prevention of miscarriage due to progesterone deficiency. |
| Women with mild to moderate progesterone deficiency or early pregnancy risk factors. |
| It provides preventive hormonal support with sustained release. |
| Intramuscular (IM) injection. |
| Yes, it is a depot (retard) formulation. |
